Folgen
Narendra Bharathy
Narendra Bharathy
Senior Research Investigator, Perelman School of Medicine, University of Pennsylvania
Bestätigte E-Mail-Adresse bei upenn.edu
Titel
Zitiert von
Zitiert von
Jahr
G9a, a multipotent regulator of gene expression
SR Shankar, AG Bahirvani, VK Rao, N Bharathy, JR Ow, R Taneja
Epigenetics 8 (1), 16-22, 2013
1992013
Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiation
BMT Ling, N Bharathy, TK Chung, WK Kok, SD Li, YH Tan, VK Rao, ...
Proceedings of the National Academy of Sciences 109 (3), 841-846, 2012
1722012
Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor
R Modak, J Basha, N Bharathy, K Maity, P Mizar, AV Bhat, M Vasudevan, ...
ACS chemical biology 8 (6), 1311-1323, 2013
622013
The HDAC3–SMARCA4–miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma
N Bharathy, NE Berlow, E Wang, J Abraham, TP Settelmeyer, JE Hooper, ...
Science signaling 11 (557), eaau7632, 2018
572018
Epigenetic regulation of skeletal muscle development and differentiation
N Bharathy, BMT Ling, R Taneja
Epigenetics: Development and Disease, 139-150, 2013
532013
G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation
VK Rao, JR Ow, SR Shankar, N Bharathy, J Manikandan, Y Wang, ...
Nucleic acids research 44 (17), 8129-8143, 2016
512016
G9a mediates Sharp-1–dependent inhibition of skeletal muscle differentiation
BMT Ling, S Gopinadhan, WK Kok, SR Shankar, P Gopal, N Bharathy, ...
Molecular biology of the cell 23 (24), 4778-4785, 2012
492012
Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism
JLY Yap, YK Tai, J Fröhlich, CHH Fong, JN Yin, ZL Foo, S Ramanan, ...
The FASEB Journal 33 (11), 12853, 2019
442019
Preclinical testing of the glycogen synthase kinase-3β inhibitor tideglusib for rhabdomyosarcoma
N Bharathy, MN Svalina, TP Settelmeyer, MM Cleary, NE Berlow, ...
Oncotarget 8 (38), 62976, 2017
242017
P/CAF mediates PAX3–FOXO1‐dependent oncogenesis in alveolar rhabdomyosarcoma
N Bharathy, S Suriyamurthy, VK Rao, JR Ow, HJ Lim, P Chakraborty, ...
The Journal of pathology 240 (3), 269-281, 2016
242016
Preclinical rationale for entinostat in embryonal rhabdomyosarcoma
N Bharathy, NE Berlow, E Wang, J Abraham, TP Settelmeyer, JE Hooper, ...
Skeletal Muscle 9, 1-10, 2019
222019
Volasertib preclinical activity in high-risk hepatoblastoma
D Kats, CA Ricker, NE Berlow, B Noblet, D Nicolle, K Mevel, ...
Oncotarget 10 (60), 6403, 2019
212019
G9a inhibits MEF2C activity to control sarcomere assembly
JR Ow, M Palanichamy Kala, VK Rao, MH Choi, N Bharathy, R Taneja
Scientific Reports 6 (1), 34163, 2016
162016
Methylation muscles into transcription factor silencing
N Bharathy, R Taneja
Transcription 3 (5), 215-220, 2012
152012
Defining the extracellular matrix of rhabdomyosarcoma
X Lian, JS Bond, N Bharathy, SP Boudko, E Pokidysheva, JF Shern, ...
Frontiers in oncology 11, 601957, 2021
142021
Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma
D Beltrán, ME Anderson, N Bharathy, TP Settelmeyer, MN Svalina, ...
Skeletal muscle 9, 1-10, 2019
102019
In vitro benchmarking of NF-κB inhibitors
AP Harrold, MM Cleary, N Bharathy, M Lathara, NE Berlow, NK Foreman, ...
European journal of pharmacology 873, 172981, 2020
82020
SMARCA4 biology in alveolar rhabdomyosarcoma
N Bharathy, MM Cleary, JA Kim, K Nagamori, KA Crawford, E Wang, ...
Oncogene 41 (11), 1647-1656, 2022
52022
Sensitization of osteosarcoma to irradiation by targeting nuclear FGFR1
JA Kim, NE Berlow, M Lathara, N Bharathy, LR Martin, R Purohit, ...
Biochemical and Biophysical Research Communications 621, 101-108, 2022
22022
Plexin-B2 and semaphorins do not drive rhabdomyosarcoma proliferation or migration
A Karki, R Purohit, S Tosoni, N Bharathy, JE Michalek, S Chen, C Keller
Sarcoma 2022, 2022
22022
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20